Jeroen DeGroot - Publications, H-index & Citations

Jeroen DeGroot

charles river laboratories

56H指数

157论文数

1.2W被引数

收录论文 60

发表时间

Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery

CELLS

IF5.2

2023-04-12

OAAI

Masmoudi, Fatma; Santos-Ferreira, Nanci; Pajkrt, Dasja; Wolthers, Katja C. C.; DeGroot, Jeroen; Vlaming, Maria L. H.; Rocha-Pereira, Joana; Buti, Ludovico

Differential effects of Nintedanib and SB525334 in primary human cell-based assays of lungfibrosis

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-25

PREAI

Pitozzi, Vanessa; Caruso, Paola; Bonatti, Martina; Sotthewes, Britt; Degroot, Jeroen; Villetti, Gino; Civelli, Maurizio; Trevisani, Marcello; Pittelli, Maria Gloria

An integrated in vitro and in vivo approach providing insights in immune modulation

CANCER RESEARCH

IF16.6

2020-08-15

PREAI

Roman, Shilina; Schueler, Julia; Holt, Sanne; DeGroot, Jeroen; Aziz, Omar; Waddell, Ian

Validation of the interaction between a candidate compound and the intended drug target by a phenotypic rescue approach

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-12-01

PREAI

Grandmoursel, Laure; Geerts, Lieke; Servant, Geraldine; van der Ham, Miranda; Maier, Armin; Aarbiou, Jamil; Vlaming, Marijn; DeGroot, Jeroen; Schuler, Julia; Waddell, Ian; Zuurmond, Anne-Marie

High content analysis of 2D and 3D oncology models for target and phenotypic drug discovery

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Lachize, Servane; van de Bospoort, Rhea; da Silva, Marta da Silva; van der Steentraten, Niki; Gowers, Ian; Clark, Roger; DeGroot, Jeroen; Waddell, Ian; Schiewe, Hajo; Jain, Shushant

Validation of the interaction between a candidate compound and the intended drug target by a phenotypic rescue approach

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Geerts, Lieke; Grandmoursel, Laure; Aarbiou, Jamil; DeGroot, Jeroen; Schueler, Julia; Waddell, Ian; Zuurmond, Anne-Marie

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients

SCIENTIFIC REPORTS

IF3.9

2019-03-14

OAAI

Chadli, Loubna; Sotthewes, Britt; Li, Kejie; Andersen, Stefan N.; Cahir-McFarland, Ellen; Cheung, Marc; Cullen, Patrick; Dorjee, Annemarie; de Vries-Bouwstra, Jeska K.; Huizinga, Tom W. J.; Fischer, David F.; DeGroot, Jeroen; Viney, Joanne L.; Zheng, Timothy S.; Aarbiou, Jamil; Gardet, Agnes

Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-04-01

OAAI

Messemaker, Tobias C.; Chadli, Loubna; Cai, Guoshuai; Goelela, Varshna S.; Boonstra, Maaike; Dorjee, Annemarie L.; Andersen, Stefan N.; Mikkers, Harald M. M.; Van't Hof, Peter; Mei, Hailiang; Distler, Oliver; Draisma, Harmen H. M.; Johnson, Michael E.; Orzechowski, Nicole M.; Simms, Robert W.; Toes, Rene E. M.; Aarbiou, Jamil; Huizinga, Tom W.; Whitfield, Michael L.; DeGroot, Jeroen; de Vries-Bouwstra, Jeska; Kurreeman, Fina

PET-CT imaging with [18F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier

NUCLEAR MEDICINE AND BIOLOGY

IF3

2015-11-01

PREAI

Vlaming, Maria L. H.; Lappchen, Tilman; Jansen, Harm T.; Kivits, Suzanne; van Driel, Andy; van de Steeg, Evita; van der Hoorn, Jose W.; Sio, Charles F.; Steinbach, Oliver C.; De Groot, Jeroen

Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2015-04-01

PREAI

van de Steeg, E.; Venhorst, J.; Jansen, H. T.; Nooijen, I. H. G.; DeGroot, J.; Wortelboer, H. M.; Vlaming, M. L. H.

Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2013-12-01

PREAI

van de Steeg, E.; Kleemann, R.; Jansen, H. T.; van Duyvenvoorde, W.; Offerman, E. H.; Wortelboer, H. M.; DeGroot, J.

Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up

OSTEOARTHRITIS AND CARTILAGE

IF9

2013-06-01

OAAI

Vos, P. A. J. M.; Welsing, P. M. J.; deGroot, J.; Huisman, A. M.; Oostveen, J. C. M.; Reijman, M.; Damen, J.; Mastbergen, S. C.; Lafeber, F. P. J. G.

Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis

OSTEOARTHRITIS AND CARTILAGE

IF9

2012-07-01

OAAI

van Spil, W. E.; Jansen, N. W. D.; Bijlsma, J. W. J.; Reijman, M.; DeGroot, J.; Welsing, P. M. J.; Lafeber, F. P. J. G.

In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage

OSTEOARTHRITIS AND CARTILAGE

IF9

2012-03-01

OAAI

Vos, P. A. J. M.; Mastbergen, S. C.; Huisman, A. M.; de Boer, T. N.; DeGroot, J.; Polak, A. A.; Lafeber, F. P. J. G.

Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2012-02-01

103

OAAI

Bastiaansen-Jenniskens, Yvonne M.; Clockaerts, Stefan; Feijt, Carola; Zuurmond, Anne-Marie; Stojanovic-Susulic, Vedrana; Bridts, Chris; de Clerck, Luc; DeGroot, Jeroen; Verhaar, Jan A. N.; Kloppenburg, Margreet; van Osch, Gerjo J. V. M.

FEASIBILITY OF LARGE-SCALE ASSESSMENT OF BIOCHEMICAL MARKERS FOR OSTEOARTHRITIS: AN ANALYSIS IN CHECK

OSTEOARTHRITIS AND CARTILAGE

IF9

2011-09-01

OAAI

van Spil, W. E.; Jansen, N. W.; Bijlsma, J. W.; Reijman, M.; DeGroot, J.; Welsing, P. M.; Lafeber, F. P.

IN A CANINE IN VIVO MODEL, ARTIFICIALLY ENHANCED NONENZYMATIC GLYCATION OF CARTILAGE DOES NOT LEAD TO DEVELOPMENT OF OSTEOARTHRITIS UPON ENFORCED JOINT LOADING

OSTEOARTHRITIS AND CARTILAGE

IF9

2011-09-01

OAAI

Vos, P.; deGroot, J.; Barten-Rijbroek, A.; Bijlsma, J.; Mastbergen, S.; Lafeber, F.

IN A CANINE IN VIVO MODEL, ARTIFICIALLY ENHANCED NONENZYMATIC GLYCATION OF CARTILAGE DOES NOT AFFECT DEVELOPMENT OF OSTEOARTHRITIS UPON MINIMAL SURGICALLY APPLIED CARTILAGE DAMAGE

OSTEOARTHRITIS AND CARTILAGE

IF9

2011-09-01

OAAI

Vos, P.; deGroot, J.; Barten-van Rijbroek, A.; van Zuurmond, A-M; Bijlsma, J.; Mastbergen, S.; Lafeber, F.

Comprehensive LC-MSE Lipidomic Analysis using a Shotgun Approach and Its Application to Biomarker Detection and Identification in Osteoarthritis Patients (vol 9, pg 2377, 2010)

JOURNAL OF PROTEOME RESEARCH

IF3.6

2011-05-31

OAAI

Castro-Perez, Jose M.; Kamphorst, Jurre; DeGroot, Jeroen; Lafeber, Floris; Goshawk, Jeff; Yu, Kate; Shockcor, John P.; Vreeken, Rob J.; Hankemeier, Thomas

Integration of efficacy, pharmacokinetic and safety assessment of interleukin-1 receptor antagonist in a preclinical model of arthritis

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2011-04-01

PREAI

Zuurmond, Anne-Marie; Koudijs, Angela; van El, Benno; Doornbos, Robert P.; van Manen-Vernooij, Babs C. T.; Bastiaans, Jacqueline H. M. W.; Penninks, Andre H.; van Bilsen, Jolanda H. M.; Cnubben, Nicole H. P.; DeGroot, Jeroen

研究方向